Skip to main content
Rheumatology (Oxford, England) logoLink to Rheumatology (Oxford, England)
. 2020 Mar 11;59(Suppl 1):i15–i20. doi: 10.1093/rheumatology/keaa040

Enthesitis in psoriatic arthritis (Part 2): imaging

Gurjit S Kaeley 1,
PMCID: PMC7065457  PMID: 32159789

Abstract

Enthesitis is a hallmark finding in PsA and may predate the onset of synovitis. Clinical examination of enthesitis provides no structural information, relies on eliciting tenderness at entheseal sites and may not be sensitive or specific. Soft tissue imaging techniques such as musculoskeletal ultrasound and MRI can depict ultrastructural and inflammatory changes. Although these imaging techniques are complimentary, ultrasound can image superficial entheses with high fidelity and examine vascularity with the use of Doppler but cannot image subchondral bone. MRI depicts bone and can visualize bone marrow edema as well as soft tissue edema. However, due to short relaxation times, entheseal structures are not easily differentiated. There has been increasing recognition of biomechanical confounding, especially since the majority of the entheses examined are in the lower extremity. Imaging entheseal indices are being developed to minimize the effect of body weight and activity. In the following article, contemporary concepts of entheses in relation to imaging will be reviewed as well as important confounders in assessing entheseal alterations. The role and limitations of imaging techniques will be discussed.

Keywords: musculoskeletal ultrasound, magnetic resonance imaging, high-resolution computed tomography, enthesitis, psoriatic arthritis, biomechanical confounding


Rheumatology key messages

  • Soft tissue imaging of entheses by ultrasound or MRI may be more sensitive than clinical examination.

  • There is increasing recognition that biomechanical confounders affect the specificity of imaging of inflammatory enthesitis.

  • The choice of entheses and ultrastructural changes impacts the specificity of entheseal imaging outcome measures.

Introduction

Enthesitis is a key manifestation of PsA and, as discussed in the accompanying supplement articles, has a significant impact on patient morbidity and function. Furthermore, in PsA patients, enthesitis is associated with radiographic damage in peripheral and axial joints. As a key manifestation, it has been included in the Classification Criteria for Psoriatic Arthritis (CASPAR) [1] and as a treatment domain for the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment guidelines [2].

Entheses – emerging concepts

Entheses are tendons or ligaments that attach to the bone. There are two main histological types of entheses: fibrous entheses and fibrocartilaginous entheses. Fibrous entheses have fibers that are directly encased in bone. Fibrous entheses such as the deltoid insertion are characterized by having a limited angle of excursion. An essential property of entheses is to dissipate force. A zone of fibrocartilage prior to the osseous margin allows for better dissipation of mechanical energy to allow for a wider angle of excursion [3]. Enthesitis related to SpA occurs at fibrocartilaginous entheses. Examples of fibrocartilaginous entheses include the supraspinatus insertion, patellar ligament attachments and Achilles tendon insertion [4]. Clinical examination of entheses depends on eliciting tenderness on direct palpation of the insertional site and may be not only nonspecific and insensitive [5], but also does not inform of the degree and chronicity of underlying structural changes. Imaging may be used to assess soft tissue and osseous changes associated with enthesitis to enable earlier diagnosis of inflammatory enthesitis as well as an opportunity to follow response to therapy.

Plain radiography

Conventional radiography is useful to document articular and periarticular features of PsA, such as erosions or new bone formation [6]. It is also useful in evaluating the spine and sacroiliac joints for evidence of SpA associated with PsA. Calcification at entheses was systematically studied at the hip and heel as well as other available plain radiographs in the CASPAR study [7]. The study enrolled 588 patients with physician-defined PsA (of which 53% had clinical enthesitis) and 525 controls, the majority of which had RA. When compared with RA subjects, PsA patients had a 3 times greater odds ratio for the prevalence of new bone formation at the inguinal ligament, sartorius and rectus femoris muscle attachment to the ilium. Although these findings were specific, the low sensitivity limits using plain radiography of these sites to distinguish PsA from RA. Although the median duration of PsA was 10 years, very few patients were found to have erosions or entheseal bone formation at the heel. The authors concluded that plain radiography for evidence of enthesopathy at major sites could not be reliably used to distinguish PsA from RA.

High-resolution peripheral quantitative CT imaging for entheses

Despite the limitations of plain radiography, there has been considerable interest in characterizing bone formation, particularly at entheseal sites around small joints. High-resolution peripheral quantitative CT can visualize bone microstructure in great detail and has been validated in osteoporosis research [8]. In a study of 30 PsA patients compared with 58 RA patients, high-resolution CT (HRCT) of the hand demonstrated differences in erosion morphology between the two groups [9]. Also, a higher number of ‘osteophytes’ were seen in the PsA group, which seemed to surround the entire bone circumference as a corona. A later study by the same authors used HRCT to examine 25 PsA patients compared with 25 patients with hand OA and 20 healthy controls [10]. HRCT of the dominant hand revealed that patients with PsA and OA had similar numbers of bone spurs. However, the location of bone formation in PsA patients was mostly at the radial aspect of the second MCP joint, whereas patients with OA had a predominance of bone formation on the dorsal and palmar aspects. Anatomic correlation suggested that bone formation in PsA subjects was prominent in the entheseal regions. Subjects with hand OA had bone spurs at the cartilage–bone margin and the joint margins. Interestingly, HRCT was used to examine 55 psoriasis patients without musculoskeletal complaints and 47 health volunteers. More enthesophtyes were found in psoriasis patients compared with controls [11]. These tended to be larger and occur on the dorsal and palmar surfaces of the metacarpal heads, which the authors suggested to be sites of functional entheses. New bone formation was therefore reported in psoriasis patients before symptoms of PsA developed. Three studies have examined enthesophyte progression in response to therapeutic intervention. Two of them were of 24 week duration, which is not a meaningful period of time to study changes in bone formation [12, 13]. A 1 year study examined MCP joints by HRCT in PsA patients treated with anti–tumor necrosis agents or methotrexate [14]. In both groups, progression of bone formation was seen, suggesting that, as in AS, current therapies may not retard entheseal bone formation.

Dual-energy CT using iodine overlay

Dual-energy CT obtains images using two X-ray tubes of different voltages, and hence energy levels. Tissue differentiation can be depicted with the aid of postprocessing software. The most common use of this in rheumatology is to depict gout deposition. A recent addition to this technique has been to map iodine after iodine contrast material has been administered [15]. The resultant image maps soft tissue lesions over the CT image. Although X-ray radiation is used, the images are acquired rapidly and are of relatively high spatial resolution. At small joints such as the distal IP joints, the resolution may be greater than that of MRI. Preliminary studies in PsA patients have reported the depiction of finger extensor tendon enthesitis, collateral ligament enthesitis, flexor tendon tenosynovitis and extensor tendon paratendinitis [16]. It remains unclear if entheseal structures can be delineated and whether this technique is feasible because of its use of radiation and intravenous contrast.

Sonographic imaging of entheses

In previous sections, the discussion has been mostly about ‘damage’ due to enthesitis. In order to assess enthesitis disease activity, as well as detailed entheseal alterations, soft tissues need to be imaged. Two common modalities include musculoskeletal ultrasound (MSK-US) and MRI. MSK-US utilizes nonionizing imaging to visualize nonaxial entheses in great detail, as the majority of them are superficial. Also, the vascularity of the entheses can be examined without the use of contrast. MSK-US can provide images in high resolution but cannot image below the bony cortex. MRI, which will be discussed below, can image bone and depict bone edema in addition to soft tissue changes.

In the following section, emerging insights into important biomechanical confounders will be highlighted. Due to significant mechanical loading, fibrocartilaginous entheses are prone to overuse injuries. At single entheseal areas, it may not be possible to distinguish changes due to overuse from those of SpA [17]. This has important implications for the selection of entheses, especially in PsA, where there are a significant proportion of patients who are obese. Using the Madrid Sonographic Enthesitis Index (MASEI), Eder et al. [18] demonstrated that they could not distinguish between healthy controls and patients with psoriasis or PsA when the BMI was >30. Similarly, Wervers et al. [19] could not distinguish PsA patients from healthy young volunteers using the MASEI methodology. The main emerging biomechanical factors are therefore mechanical loading due to obesity as well as repetitive physical activity or overloading. Also, distinguishing diseased vs physiologic entheseal changes in physically active adults may be difficult at some entheses.

Sonographic indices were developed in patients with AS or in mixed populations and did not account for these confounders. Of note, most of these indices include lower extremity entheses that are prone to mechanical loading. The ideal balance for an entheseal index is the selection of entheses that are frequently affected in PsA but minimally affected by biomechanical confounders. A summary of the conventional indices is given in Table 1. The GRAPPA ultrasound group [20] has attempted to ameliorate these confounders by using a data-driven approach to select entheses (Table 1). As a result of the regression elimination of entheseal sites from pilot data, more upper extremity entheses were included compared with the other indices, which may minimize the impact of obesity on the proposed GRAPPA ultrasound index. Another approach has been to study entheses of the hand. Zabotti et al. [21] demonstrated that ultrasound of the entheses of the hand and finger could differentiate early PsA from early RA. The key discriminative lesions included MCP joint peritonitis and proximal IP joint central slip enthesitis.

Table 1.

Selected ultrasound entheseal indices

Site GUESS MASEI GRAPPA US OMERACT US
Bilateral Achilles enthesis + + + +
Bilateral plantar fascia + + +
Bilateral proximal patellar ligament attachments + + + +
Bilateral distal patellar ligament attachments +
Bilateral quadriceps insertion + + + +
Bilateral triceps insertion + +
Bilateral lateral epicondyle + +
Bilateral supraspinatus +
Doppler within 2 mm of the cortex of the enthesis + + +
Doppler >2 mm from the cortex of the enthesis + +
Doppler at bursa + +

GUESS: Glasgow Ultrasound Enthesitis Score [22]; MASEI: Madrid Sonography Enthesitis Index [23]; GRAPPA US: proposed entheseal sites by the GRAPPA Ultrasound Working Group [20]; OMERACT US: proposed entheseal sites by the OMERACT Ultrasound Enthesitis Working Group [24].

Enthesitis ultrastructural changes

Alterations in the enthesis in patients with SpA not only occur at the attachment but also in the surrounding force dissipation structures. These include the adjacent tendon, bursa and bone. Bony changes on sonography can be seen as superficial erosions. Of note, one drawback of sonography is that it cannot visualize structures below the cortex and hence bone edema cannot be detected. However, changes to the entheses and adjoining tendons, such as thickening and increased hypoechogenicity, as well as bursitis, may be reversible on appropriate treatment. In contrast, enthesophyte formation, intratendinous calcification, intratendinous tears and bone erosions are nonreversible and are considered indications of damage [25]. The OMERACT ultrasound enthesitis group has published a consensus-based definition of enthesitis that includes changes to the enthesis and bone but not adjacent bursa or tendon. Furthermore, the definition restricts the Doppler signal to within 2 mm of the cortical bone margin, which is problematic since it does not account for enthesis size. Also, the group found that the prevalence of Doppler signal was higher with a tendon attachment area at >2 mm [24]. Macia-Villa et al. [23] examined the prevalence of Doppler signal at the enthesis in 27 active PsA patients. Doppler signal was present in 81.5% of their patients and always appeared in more than one area of the enthesis complex. The GRAPPA Ultrasound Working Group has proposed a data-driven approach where Doppler signal will be analyzed according to the location within and distal to 2 mm of the bone cortex as well as the bursa [20]. This is keeping with increasing awareness that there are increased inflammatory mediators in insertional tendinopathies [26] that which may overlap with those due to enthesitis.

Role of sonography for differentiating PsA inflammatory disease from central sensitization

One key use of sonography is to provide objective evidence of inflammation when there is patient–evaluator discordance, such as in pain sensitization syndromes. A significant proportion of patients with PsA may have coexisting central sensitization syndrome, which may bias clinical outcome measures. When evaluating newly presenting patients, one question may be to differentiate FM syndrome from PsA. Marchesoni et al. [27] reported in a multicenter cross-sectional study that the number of clinical symptoms and tender points had the highest discriminating power in separating these groups. Thirty patients, each with PsA, also underwent sonography. When sonographic signs of enthesopathy were utilized in three or more entheses, the two groups could be separated with moderate discrimination [28]. Marchioni et al. [29] found similar findings in a more extensive multicenter cross-sectional study. Of note, the frequency of clinical entheseal tenderness was higher in FM syndrome patients and sonographic features of chronic and inflammatory features were more common in PsA patients. Although the BMI in this group of patients was <30 kg/m2, age and BMI influenced overall sonographic B-mode structural scores, underpinning the importance of biomechanical factors in the expression of enthesopathy.

MRI for evaluation of entheses

MRI is a sectional imaging technique that produces fat-sensitive (T1 weighted) or water-sensitive (T2 weighted) images. Furthermore, short tau inversion recovery (STIR) sequences suppress fat and are useful to demonstrate bone edema in addition to other water-sensitive pathologies such as synovitis and tenosynovitis. Gadolinium contrast, coupled with T1 weighted imaging, depicts tissue vascularity. Although MRI offers excellent potential in imaging entheseal structures, there are important technical considerations. For example, high-resolution images need higher-strength magnets and coils compared with the low Tesla (0.2 T) equipment available at the point of care [30]. Also, technical details such as slice thickness and the angle of tendons to avoid magic angle artifacts are important considerations that affect image fidelity [31]. Lastly, conventional parameters used for MRI do not adequately characterize tendons and entheses because the enthesis and adjoining tendon have short transverse relaxation times. MR signals from these tissues decay rapidly, and because no information is received, the tissues appear dark. In order to overcome this problem, protocols using ultrashort echo times are being developed [32–34]. In a recent study of cadaveric ankles, the enthesis could be seen separately from the tendon using an 11.7 T magnet and ultrashort echo time sequences [34]. Due to a lack of ultrastructural detail, MRI may not be useful in distinguishing patients with enthesitis from those with other inflammatory arthritides or healthy subjects [35, 36]. Interestingly, in a recent study of heel and knee entheses by both MRI and ultrasound, neither modality could distinguish between peripheral SpA patients and healthy subjects [35]. At the heel, only B-mode changes distinguished the two groups, and MRI findings were similar. In an earlier study, inflammatory findings by MRI or ultrasound of the heel could not distinguish SpA patients from healthy subjects [37]. Altogether, this is yet further evidence for the biomechanical overlay of findings at the entheses, which has important implications for diagnostic and therapeutic studies.

In a recent systematic literature review on MRI in diagnosing and monitoring enthesitis in patients with SpA, lack of a validated, comprehensive scoring system was recognized but technical limitations were not addressed [38]. The OMERACT MRI group has reported efforts in developing an MRI scoring system for SpA/PsA using the heel as a model [39]. Both inflammatory and structural abnormalities were included in the preliminary heel enthesitis scoring system (OMERACT-HEMRIS). Among all readers, inflammatory changes had good interreader reliability, while structural changes such as enthesophyte formation and bone erosion had poor reliability.

One of the key disadvantages of MRI is the limitation to a single body area for scanning. Whole-body MRI (WB-MRI) is currently being advanced as a technique that can image multiple areas of the body in one scan done in <1 h [40]. WB-MRI was initially developed to image from the head to the pelvis for metastases. The technique has been adopted to view the whole body. Of note, additional body coils are needed for the extremities and gadolinium may be needed to elicit subtle enthesitis [41]. Two studies using WB-MRI in PsA patients have reported increased sensitivity of detecting enthesitis based on bone marrow edema at entheseal sites compared with clinical exam [41, 42]. However, in one study, signs of enthesitis were also present at several entheseal locations in healthy subjects [42]. These findings further reinforce the contemporary theme of biomechanical confounding at entheses. The OMERACT MRI group is developing scoring systems for WB-MRI. It remains to be seen if the specificity of findings at the entheses can be improved.

Future directions

Sonography and MRI can image many of the peripheral entheses and provide ultrastructural information as well as relative vascularity of the structures. Given the significant biomechanical confounders, further research needs to be done to establish a candidate set of entheses that can be used across diverse populations. Similarly, the choice of ultrastructural elements, as well as the region of vascularity, needs to be examined across populations with a wide range of BMIs and physical activity. Finally, imaging of entheseal and force dissipating structures is providing an anatomical backstage for understanding the interplay between innate and adaptive immunity in daily life as well as in patients with PsA.

Funding: No specific funding was received from any funding bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article. This paper was published as part of a supplement funded by an educational grant from Novartis.

Disclosure statement: G.S.K. has received consultancy fees from Novartis, served on advisory boards for Horizon and Janssen and received research grants from AbbVie, Pfizer, Gilead, Eli Lilly and GlaxoSmithKline.

References

  • 1. Taylor W, Gladman D, Helliwell P. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665–73. [DOI] [PubMed] [Google Scholar]
  • 2. Coates LC, Kavanaugh A, Mease PJ. et al. Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 2016;68:1060–71. [DOI] [PubMed] [Google Scholar]
  • 3. Apostolakos J, Durant TJ, Dwyer CR. et al. The enthesis: a review of the tendon-to-bone insertion. Muscles Ligaments Tendons J 2014;4:333–42. [PMC free article] [PubMed] [Google Scholar]
  • 4. Benjamin M, McGonagle D.. The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 2001;199(Pt 5):503–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Kaeley GS, Eder L, Aydin SZ, Gutierrez M, Bakewell C.. Enthesitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 2018;48:35–43. [DOI] [PubMed] [Google Scholar]
  • 6. Anandarajah A. Imaging in psoriatic arthritis. Clin Rev Allergy Immunol 2013;44:157–65. [DOI] [PubMed] [Google Scholar]
  • 7. Helliwell PS, Porter G; CASPAR study group. Sensitivity and specificity of plain radiographic features of peripheral enthesopathy at major sites in psoriatic arthritis. Skeletal Radiol 2007;36:1061–6. [DOI] [PubMed] [Google Scholar]
  • 8. Nagaraj S, Finzel S, Stok KS, Barnabe C; the SPECTRA Collaboration. High-resolution peripheral quantitative computed tomography imaging in the assessment of periarticular bone of metacarpophalangeal and wrist joints. J Rheumatol 2016;43:1921–34. [DOI] [PubMed] [Google Scholar]
  • 9. Finzel S, Englbrecht M, Engelke K, Stach C, Schett G.. A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis 2011;70:122–7. [DOI] [PubMed] [Google Scholar]
  • 10. Finzel S, Sahinbegovic E, Kocijan R. et al. Inflammatory bone spur formation in psoriatic arthritis is different from bone spur formation in hand osteoarthritis. Arthritis Rheumatol 2014;66:2968–75. [DOI] [PubMed] [Google Scholar]
  • 11. Simon D, Faustini F, Kleyer A. et al. Analysis of periarticular bone changes in patients with cutaneous psoriasis without associated psoriatic arthritis. Ann Rheum Dis 2016;75:660–6. [DOI] [PubMed] [Google Scholar]
  • 12. Poggenborg R, Bird P, Boonen A. et al. Pattern of bone erosion and bone proliferation in psoriatic arthritis hands: a high-resolution computed tomography and radiography follow-up study during adalimumab therapy. Scand J Rheumatol 2014;43:202–8. [DOI] [PubMed] [Google Scholar]
  • 13. Kampylafka E, d’Oliveira I, Linz C. et al. Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study. Arthritis Res Ther 2018;20:153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Finzel S, Kraus S, Schmidt S. et al. Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors. Ann Rheum Dis 2013;72:1176–81. [DOI] [PubMed] [Google Scholar]
  • 15. Fukuda T, Fukuda K.. The role of dual-energy computed tomography in musculoskeletal imaging. PET Clin 2018;13:567–78. [DOI] [PubMed] [Google Scholar]
  • 16. Fukuda T, Umezawa Y, Asahina A, Nakagawa H, Furuya K, Fukuda K.. Dual energy CT iodine map for delineating inflammation of inflammatory arthritis. Eur Radiol 2017;27:5034–40. [DOI] [PubMed] [Google Scholar]
  • 17. Abate M. How obesity modifies tendons (implications for athletic activities). Muscles Ligaments Tendons J 2019;4:298–302. [PMC free article] [PubMed] [Google Scholar]
  • 18. Eder L, Jayakar J, Thavaneswaran A. et al. Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? J Rheumatol 2014;41:466–72. [DOI] [PubMed] [Google Scholar]
  • 19. Wervers K, Vis M, Rasappu N, van der Ven M. et al. Modification of a sonographic enthesitis score to differentiate between psoriatic arthritis and young healthy volunteers. Scand J Rheumatol 2018;47:291–4. [DOI] [PubMed] [Google Scholar]
  • 20. Tom S, Zhong Y, Cook R, Aydin SZ. et al. Development of a preliminary ultrasonographic enthesitis score in psoriatic arthritis—GRAPPA Ultrasound Working Group. J Rheumatol 2019;46:384–90. [DOI] [PubMed] [Google Scholar]
  • 21. Zabotti A, Salvin S, Quartuccio L, De Vita S.. Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands. Clin Exp Rheumatol 2016;34:459–65. [PubMed] [Google Scholar]
  • 22. Balint PV, Kane D, Wilson H, McInnes IB, Sturrock RD.. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002;61:905–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Macía-Villa C, Falcao S, Medina J, Miguel ED.. Ultrasonography of enthesis in psoriatic arthritis: a descriptive and reliability analysis of elemental lesions and power Doppler subtypes. Scand J Rheumatol 2019;48:454–9. [DOI] [PubMed] [Google Scholar]
  • 24. Balint PV, Terslev L, Aegerter P. et al. Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative. Ann Rheum Dis 2018;77:1730–5. [DOI] [PubMed] [Google Scholar]
  • 25. Elalouf O, Bakirci Ureyen S, Touma Z. et al. Psoriatic arthritis sonographic enthesitis instruments: a systematic review of the literature. J Rheumatol 2019;46:43–56. [DOI] [PubMed] [Google Scholar]
  • 26. Tang C, Chen Y, Huang J. et al. The roles of inflammatory mediators and immunocytes in tendinopathy. J Orthop Transl 2018;14:23–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Marchesoni A, Atzeni F, Spadaro A. et al. Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 2012;39:849–55. [DOI] [PubMed] [Google Scholar]
  • 28. Marchesoni A, De Lucia O, Rotunno L, De Marco G, Manara M.. Entheseal power Doppler ultrasonography: a comparison of psoriatic arthritis and fibromyalgia. J Rheumatol Suppl 2012;89:29–31. [DOI] [PubMed] [Google Scholar]
  • 29. Macchioni P, Salvarani C, Possemato N. et al. Ultrasonographic and clinical assessment of peripheral enthesitis in patients with psoriatic arthritis, psoriasis, and fibromyalgia syndrome: the ULISSE study. J Rheumatol 2019;46:904–11. [DOI] [PubMed] [Google Scholar]
  • 30. Eshed I, Bollow M, McGonagle DG. et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis 2007;66:1553–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Bydder M, Rahal A, Fullerton GD, Bydder GM.. The magic angle effect: a source of artifact, determinant of image contrast, and technique for imaging. J Magn Reson Imaging 2007;25:290–300. [DOI] [PubMed] [Google Scholar]
  • 32. Robson MD, Gatehouse PD, Bydder M, Bydder GM.. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J Comput Assist Tomogr 2003;27:825–46. [DOI] [PubMed] [Google Scholar]
  • 33. Benjamin M, Bydder GM.. Magnetic resonance imaging of entheses using ultrashort TE (UTE) pulse sequences. J Magn Reson Imaging 2007;25:381–9. [DOI] [PubMed] [Google Scholar]
  • 34. Chen B, Cheng X, Dorthe EW. et al. Evaluation of normal cadaveric Achilles tendon and enthesis with ultrashort echo time (UTE) magnetic resonance imaging and indentation testing. NMR Biomed 2019;32:e4034. [DOI] [PubMed] [Google Scholar]
  • 35. Baraliakos X, Kiltz U, Appel H. et al. Chronic but not inflammatory changes at the Achilles’ tendon differentiate patients with peripheral spondyloarthritis from other diagnoses – results from a prospective clinical trial. RMD Open 2017;3:e000541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Felbo SK, Terslev L, Østergaard M.. Imaging in peripheral and axial psoriatic arthritis: contributions to diagnosis, follow-up, prognosis and knowledge of pathogenesis. Clin Exp Rheumatol 2018;36(Suppl 114):S24–34. [PubMed] [Google Scholar]
  • 37. Feydy A, Lavie-Brion M-C, Gossec L. et al. Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls. Ann Rheum Dis 2012;71:498–503. [DOI] [PubMed] [Google Scholar]
  • 38. Mathew AJ, Krabbe S, Kirubakaran R. et al. Utility of magnetic resonance imaging in diagnosis and monitoring enthesitis in patients with spondyloarthritis: an OMERACT systematic literature review. J Rheumatol 2019;46:1207–14. [DOI] [PubMed] [Google Scholar]
  • 39. Mathew AJ, Krabbe S, Eshed I. et al. The OMERACT MRI in enthesitis initiative: definitions of key pathologies, suggested MRI sequences and novel Heel Enthesitis Scoring System (HEMRIS). J Rheumatol 2019;46:1232–8. [DOI] [PubMed] [Google Scholar]
  • 40. Lecouvet FE. Whole-body MR imaging: musculoskeletal applications. Radiology 2016;279:345–65. [DOI] [PubMed] [Google Scholar]
  • 41. Weckbach S, Schewe S, Michaely HJ. et al. Whole-body MR imaging in psoriatic arthritis: additional value for therapeutic decision making. Eur J Radiol 2011;77:149–55. [DOI] [PubMed] [Google Scholar]
  • 42. Poggenborg RP, Eshed I, Østergaard M. et al. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by ‘head-to-toe’ whole-body MRI and clinical examination. Ann Rheum Dis 2015;74:823–9. [DOI] [PubMed] [Google Scholar]

Articles from Rheumatology (Oxford, England) are provided here courtesy of Oxford University Press

RESOURCES